Biotivity A-C Membrane Socket Preservation Study
NCT: NCT07091448 · NOT_YET_RECRUITING
Brief Summary
This is a prospective, randomized controlled pilot clinical trial evaluating the efficacy of a human placental-derived amnion chorion membrane (Biotivity™ A/C Plus Membrane) versus a conventional collagen membrane in alveolar ridge preservation (ARP) following atraumatic extraction of single posterior teeth. A total of 12 subjects will be enrolled at the University of Maryland School of Dentistry. The study aims to assess both soft tissue wound healing and hard/soft tissue dimensional changes over a 5-month period prior to dental implant placement. Throughout the approximately 6-month study duration, participants will undergo oral exams, x-rays, surgical procedures, and follow-up visits. All participants will undergo routine tooth extraction, bone graft material and barrier placement, and dental implant placement. Participation in the study is voluntary, and the alternative is to continue routine dental care. Risks include minor discomfort from procedures such as tooth extraction and implant placement. The major benefit of participation in the study is the preservation of jaw dimensions following extraction, which will simplify the placement of a dental implant.
Frequently Asked Questions
What is Biotivity A-C Membrane Socket Preservation Study?
Biotivity A-C Membrane Socket Preservation Study is a clinical trial registered under NCT07091448. Current status: NOT_YET_RECRUITING.
What is the status of NCT07091448?
The current status of NCT07091448 (Biotivity A-C Membrane Socket Preservation Study) is: NOT_YET_RECRUITING.
When did Biotivity A-C Membrane Socket Preservation Study start?
Biotivity A-C Membrane Socket Preservation Study started on 2026-08-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.